Giving patients information on abnormal cytology and human papillomavirus: Survey of health providers

Objectives: Knowledge of the link between HPV and cervical cancer is low among women. Health providers may be required to give information and counseling on HPV. This study surveyed health providers' comfort in counseling women about HPV.

Methods: Physicians, nurses and midwives attending a lecture on HPV completed a questionnaire (before the lecture) on their comfort level answering questions that a woman with an abnormal Pap may ask her health provider. Comfort level with knowledge was assessed on a 7-point Likert scale, with seven being very comfortable.

Results: Of the 96 attendees, 57.3% (55/96) were eligible and completed the questionnaire. Two-thirds of respondents were physicians (61.8%; 34/55), 38.2% were nurses or midwives (21/55). Telling a partner about HPV infection was the question about which the most respondents were very comfortable (69.1% answering 6 or 7) and chances of developing cervical cancer was the item about which the fewest respondents reported being very comfortable (36.4%).

Conclusions: Less than one-half to two-thirds of health providers self-reported being very comfortable answering HPV-related questions that a woman may ask. More information is needed regarding health providers' actual knowledge of HPV and women's wishes for information.

Human papillomavirus; Counseling; Health personnel; Survey

[1] Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S.: "Human papillomavirus types in invasive cervical cancer world­wide: a meta-analysis". Br. J. Cancer, 2003, 88, 63.

[2] Wright T.C. Jr, Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J and the ASCCP-Sponsored Consensus Conference. "2001 Con­sensus Guidelines for the management of women with cervical cytological abnormalities". J. Am. Med. Assoc., 2002, 287, 2120.

[3] Anhang R., Goodan A., Goldie S.J.: "HPV communication: review of existing research and recommendations for patient education". CA Cancer J. Clin., 2004, 54, 248.

[4] Stuart G., Taylor G., Bancej C.M., Beaulac J., Colgan T., Franco E. L.: "Report of the 2003 pan-Canadian forum on cervical cancer prevention and control". J. Obstet. Gynaecol. Can., 2004, 26, 1004.

[5] Waller J., McCaffery K., Nazroo J., Wardle J.: "Making sense of information about HPV in cervical screening: a qualitative study" Br. J. Cancer, 2005, 92, 265.

[6] Gilbert L.K., Alexander L., Grosshans J.F., Jolley L.: "Answenng frequently asked questions about HPV". Sex Transm. Dis., 2003, 30, 193.

[7] Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., Rosenthal S.L.: "Pediatricians'intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge and attitudes". J. Adolesc. Health, 2005, 37, 502.

[8] Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., Kahn J.: "Attitudes about human papillomavirus vaccine among family physicians". J. Pediatr. Adolesc. Gynecol., 2005, I 8, 391.

[9] Aldrich T., Becker D., Garcia S.G., Lara D.: "Mexican physicians' knowledge and attitudes about the human papillomavirus and cer­vical cancer: a national survey". Sex. Transm. Infect., 2005, 81, 135.

[10] McCaffrey K., Waller J., Forrest S., Cadman L., Szarewski A., Wardle J.: "Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact". Br. J Obstet. Gynecol., 2004, 111, 1437.

[11] Green J.: "Psychosocial issues in genital herpes management". Herpes, 2004, 11, 60.

[12] Schiffman M., Kruger Kjaer S.: "Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia". J. Natl. Cancer Inst. Monogr., 2003, 31, 14.